Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Swept-Source OCT Angiography Characterization of Macular Telangiectasia Type 2 Spectrum.
Author Affiliations & Notes
  • Isabella Stettler
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Francesco Romano
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Katherine M Overbey
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Cade F Bennett
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Xinyi Ding
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Itika Garg
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Filippos Vingopoulos
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Peyman Razavi
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Matthew Finn
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Ioanna Ploumi
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Mauricio De Jesus Garcia
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Sandra Alhoyek
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Nimesh Arvind Patel
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Demetrios Vavvas
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Joan W Miller
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • John B Miller
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Isabella Stettler None; Francesco Romano None; Katherine Overbey None; Cade Bennett None; Xinyi Ding None; Itika Garg None; Filippos Vingopoulos None; Peyman Razavi None; Matthew Finn None; Ioanna Ploumi None; Mauricio Garcia None; Sandra Alhoyek None; Nimesh Patel Alimera Sciences, Alcon, Allergan, Genentech, Eyepoint, Lifesciences Guidepoint, and GLG, Code C (Consultant/Contractor), Financial support from the Retina Innovation Fund, Massachusetts Eye and Ear, Boston, MA, Code F (Financial Support); Demetrios Vavvas Olix Pharma, Valitor, TwentyTwenty, Sumitomo/Sunovion, Cambridge Polymer Group, Code C (Consultant/Contractor), National Eye Institute, NIH, Research to Prevent Blindness, Loefflers Family Foundation, Yeatts Family Foundation, and Alcon Research Institute, Code F (Financial Support), Drusolv Therapeutics, Code O (Owner), MASS EYE and EAR, Code P (Patent); Joan Miller Sunovion, Genentech/ Roche, KalVista Pharmaceuticals, ONL Therapeutics, Heidelberg Engineering, Code C (Consultant/Contractor), Lowy Medical Research Institute, National Eye Institute, Heidelberg Engineering, Code F (Financial Support), Ciendias Bio, Code I (Personal Financial Interest), Drusolv Therapeutics, ONL Therapeutics, Valeant Pharmaceuticals/Mass. Eye and Ear, Code P (Patent), Aptinyx, Inc., Sunovion, KalVista Pharmaceuticals, ONL Therapeutics, Valeant Pharmaceuticals/Mass. Eye and Ear, Code R (Recipient), Aptinyx, Inc., ONL Therapeutics, Code S (non-remunerative); John Miller Alcon, Allergan, Carl Zeiss, Sunovion, Genentech and Topcon, Code C (Consultant/Contractor)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 3889. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Isabella Stettler, Francesco Romano, Katherine M Overbey, Cade F Bennett, Xinyi Ding, Itika Garg, Filippos Vingopoulos, Peyman Razavi, Matthew Finn, Ioanna Ploumi, Mauricio De Jesus Garcia, Sandra Alhoyek, Nimesh Arvind Patel, Demetrios Vavvas, Joan W Miller, John B Miller; Swept-Source OCT Angiography Characterization of Macular Telangiectasia Type 2 Spectrum.. Invest. Ophthalmol. Vis. Sci. 2024;65(7):3889.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate the retinal microvascular and choriocapillaris changes in the recently proposed 7-step classification for Macular Telangiectasia type 2 (MacTel) employing swept-source optical coherence tomography angiography (SS-OCTA).

Methods : Cross-sectional, observational study including MacTel eyes with visual acuity >20/200, good-quality macular SS-OCTA (signal strength index >7, no artifacts) and no other ocular/systemic comorbidities. MacTel eyes were categorized into one of the 7 grades (0-6) proposed by the MacTel Project based on multimodal imaging. 6x6-mm OCTA scans (PLEX Elite 9000; Carl Zeiss Meditec, Dublin, CA) were processed using the macular density algorithm (v.0.7.3.3) on the Advanced Research and Innovation (ARI) Network portal to measure vessel density (VD) and vessel skeletonized density (VSD). Choriocapillaris was analyzed in FIJI by measuring inner choroidal flow deficit percentage (ICFD%) for 15-µm slabs, after compensation and binarization with Phansalkar method (r=15). All analyses were performed for 6-, 3- and 1-mm circles and various ETDRS sectors. Kruskal-Wallis test with Dunn’s post-hoc test was used to compare the different grades. Generalized linear mixed-effects models, adjusting for age and grade, with patient-based nesting, were employed to correlate retinal and choriocapillaris perfusion alterations.

Results : A total of 111 eyes (56 patients) were included (median age 63, 64% female). 36 eyes were classified as grade 0 (32%), 10 as grade 1 (9%), 20 as grade 2 (18%), 5 as grade 3 (5%), 17 as grade 4 (15%), 14 as grade 5 (13%), 9 as grade 6 (8%). Eyes with more advanced MacTel grades (5-6) exhibited significant differences in VD and VSD compared with lower-grade eyes (0-2), particularly in temporal and superior sectors. Grade 5 MacTel eyes had significantly greater ICFD% compared to grade 0 across all analyzed areas. Further, ICFD% positively correlated with advanced MacTel grades and negatively correlated with VD and VSD in multiple ETDRS sectors.

Conclusions : This is the first comprehensive SS-OCTA assessment across the recently proposed grades for MacTel classification. The observed differences in retinal and choriocapillaris perfusion suggest distinct characteristics between early and advanced stages of MacTel. Further longitudinal studies are warranted to better characterize the impact of microvascular alterations on the pathogenesis and progression of MacTel.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×